Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.

Identifieur interne : 000743 ( PubMed/Curation ); précédent : 000742; suivant : 000744

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.

Auteurs : Abeer N. Alshukairi ; Jian Zheng [États-Unis] ; Jingxian Zhao [République populaire de Chine] ; Atef Nehdi ; Salim A. Baharoon ; Laila Layqah ; Ahmad Bokhari ; Sameera M. Al Johani ; Nosaibah Samman ; Mohamad Boudjelal ; Patrick Ten Eyck [États-Unis] ; Maha A. Al-Mozaini ; Jincun Zhao [République populaire de Chine] ; Stanley Perlman [États-Unis] ; Abdulaziz N. Alagaili [États-Unis]

Source :

RBID : pubmed:30377284

Descripteurs français

English descriptors

Abstract

Middle East respiratory syndrome (MERS), a highly lethal respiratory disease caused by a novel coronavirus (MERS-CoV), is an emerging disease with high potential for epidemic spread. It has been listed by the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) as an important target for vaccine development. While initially the majority of MERS cases were hospital acquired, continued emergence of MERS is attributed to community acquisition, with camels likely being the direct or indirect source. However, the majority of patients do not describe camel exposure, making the route of transmission unclear. Here, using sensitive immunological assays and a cohort of camel workers (CWs) with well-documented camel exposure, we show that approximately 50% of camel workers (CWs) in the Kingdom of Saudi Arabia (KSA) and 0% of controls were previously infected. We obtained blood samples from 30 camel herders, truck drivers, and handlers with well-documented camel exposure and from healthy donors, and measured MERS-CoV-specific enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and neutralizing antibody titers, as well as T cell responses. Totals of 16/30 CWs and 0/30 healthy control donors were seropositive by MERS-CoV-specific ELISA and/or neutralizing antibody titer, and an additional four CWs were seronegative but contained virus-specific T cells in their blood. Although virus transmission from CWs has not been formally demonstrated, a possible explanation for repeated MERS outbreaks is that CWs develop mild disease and then transmit the virus to uninfected individuals. Infection of some of these individuals, such as those with comorbidities, results in severe disease and in the episodic appearance of patients with MERS.IMPORTANCE The Middle East respiratory syndrome (MERS) is a coronavirus (CoV)-mediated respiratory disease. Virus transmission occurs within health care settings, but cases also appear sporadically in the community. Camels are believed to be the source for community-acquired cases, but most patients do not have camel exposure. Here, we assessed whether camel workers (CWs) with high rates of exposure to camel nasal and oral secretions had evidence of MERS-CoV infection. The results indicate that a high percentage of CWs were positive for virus-specific immune responses but had no history of significant respiratory disease. Thus, a possible explanation for repeated MERS outbreaks is that CWs develop mild or subclinical disease. These CWs then transmit the virus to uninfected individuals, some of whom are highly susceptible, develop severe disease, and are detected as primary MERS cases in the community.

DOI: 10.1128/mBio.01985-18
PubMed: 30377284

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:30377284

Curation

No country items

Abeer N. Alshukairi
<affiliation>
<nlm:affiliation>Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudia Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudia Arabia</wicri:noCountry>
</affiliation>
Atef Nehdi
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Salim A. Baharoon
<affiliation>
<nlm:affiliation>Department of Critical Care, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Laila Layqah
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Ahmad Bokhari
<affiliation>
<nlm:affiliation>Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Sameera M. Al Johani
<affiliation>
<nlm:affiliation>College of Science and Health Professions, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Nosaibah Samman
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Mohamad Boudjelal
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
Maha A. Al-Mozaini
<affiliation>
<nlm:affiliation>Department of Infection and Immunology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.</title>
<author>
<name sortKey="Alshukairi, Abeer N" sort="Alshukairi, Abeer N" uniqKey="Alshukairi A" first="Abeer N" last="Alshukairi">Abeer N. Alshukairi</name>
<affiliation>
<nlm:affiliation>Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudia Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudia Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Zheng, Jian" sort="Zheng, Jian" uniqKey="Zheng J" first="Jian" last="Zheng">Jian Zheng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Jingxian" sort="Zhao, Jingxian" uniqKey="Zhao J" first="Jingxian" last="Zhao">Jingxian Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nehdi, Atef" sort="Nehdi, Atef" uniqKey="Nehdi A" first="Atef" last="Nehdi">Atef Nehdi</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Baharoon, Salim A" sort="Baharoon, Salim A" uniqKey="Baharoon S" first="Salim A" last="Baharoon">Salim A. Baharoon</name>
<affiliation>
<nlm:affiliation>Department of Critical Care, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Layqah, Laila" sort="Layqah, Laila" uniqKey="Layqah L" first="Laila" last="Layqah">Laila Layqah</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bokhari, Ahmad" sort="Bokhari, Ahmad" uniqKey="Bokhari A" first="Ahmad" last="Bokhari">Ahmad Bokhari</name>
<affiliation>
<nlm:affiliation>Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Al Johani, Sameera M" sort="Al Johani, Sameera M" uniqKey="Al Johani S" first="Sameera M" last="Al Johani">Sameera M. Al Johani</name>
<affiliation>
<nlm:affiliation>College of Science and Health Professions, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Samman, Nosaibah" sort="Samman, Nosaibah" uniqKey="Samman N" first="Nosaibah" last="Samman">Nosaibah Samman</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Boudjelal, Mohamad" sort="Boudjelal, Mohamad" uniqKey="Boudjelal M" first="Mohamad" last="Boudjelal">Mohamad Boudjelal</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ten Eyck, Patrick" sort="Ten Eyck, Patrick" uniqKey="Ten Eyck P" first="Patrick" last="Ten Eyck">Patrick Ten Eyck</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Al Mozaini, Maha A" sort="Al Mozaini, Maha A" uniqKey="Al Mozaini M" first="Maha A" last="Al-Mozaini">Maha A. Al-Mozaini</name>
<affiliation>
<nlm:affiliation>Department of Infection and Immunology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Perlman, Stanley" sort="Perlman, Stanley" uniqKey="Perlman S" first="Stanley" last="Perlman">Stanley Perlman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA stanley-perlman@uiowa.edu aalagaili@ksu.edu.sa.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alagaili, Abdulaziz N" sort="Alagaili, Abdulaziz N" uniqKey="Alagaili A" first="Abdulaziz N" last="Alagaili">Abdulaziz N. Alagaili</name>
<affiliation wicri:level="1">
<nlm:affiliation>KSU Mammals Research Chair, Zoology Department, King Saud University, Riyadh, Kingdom of Saudi Arabia stanley-perlman@uiowa.edu aalagaili@ksu.edu.sa.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>KSU Mammals Research Chair, Zoology Department, King Saud University, Riyadh</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30377284</idno>
<idno type="pmid">30377284</idno>
<idno type="doi">10.1128/mBio.01985-18</idno>
<idno type="wicri:Area/PubMed/Corpus">000743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000743</idno>
<idno type="wicri:Area/PubMed/Curation">000743</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000743</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.</title>
<author>
<name sortKey="Alshukairi, Abeer N" sort="Alshukairi, Abeer N" uniqKey="Alshukairi A" first="Abeer N" last="Alshukairi">Abeer N. Alshukairi</name>
<affiliation>
<nlm:affiliation>Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudia Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudia Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Zheng, Jian" sort="Zheng, Jian" uniqKey="Zheng J" first="Jian" last="Zheng">Jian Zheng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Jingxian" sort="Zhao, Jingxian" uniqKey="Zhao J" first="Jingxian" last="Zhao">Jingxian Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nehdi, Atef" sort="Nehdi, Atef" uniqKey="Nehdi A" first="Atef" last="Nehdi">Atef Nehdi</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Baharoon, Salim A" sort="Baharoon, Salim A" uniqKey="Baharoon S" first="Salim A" last="Baharoon">Salim A. Baharoon</name>
<affiliation>
<nlm:affiliation>Department of Critical Care, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Layqah, Laila" sort="Layqah, Laila" uniqKey="Layqah L" first="Laila" last="Layqah">Laila Layqah</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bokhari, Ahmad" sort="Bokhari, Ahmad" uniqKey="Bokhari A" first="Ahmad" last="Bokhari">Ahmad Bokhari</name>
<affiliation>
<nlm:affiliation>Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Al Johani, Sameera M" sort="Al Johani, Sameera M" uniqKey="Al Johani S" first="Sameera M" last="Al Johani">Sameera M. Al Johani</name>
<affiliation>
<nlm:affiliation>College of Science and Health Professions, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Samman, Nosaibah" sort="Samman, Nosaibah" uniqKey="Samman N" first="Nosaibah" last="Samman">Nosaibah Samman</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Boudjelal, Mohamad" sort="Boudjelal, Mohamad" uniqKey="Boudjelal M" first="Mohamad" last="Boudjelal">Mohamad Boudjelal</name>
<affiliation>
<nlm:affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ten Eyck, Patrick" sort="Ten Eyck, Patrick" uniqKey="Ten Eyck P" first="Patrick" last="Ten Eyck">Patrick Ten Eyck</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Al Mozaini, Maha A" sort="Al Mozaini, Maha A" uniqKey="Al Mozaini M" first="Maha A" last="Al-Mozaini">Maha A. Al-Mozaini</name>
<affiliation>
<nlm:affiliation>Department of Infection and Immunology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.</nlm:affiliation>
<wicri:noCountry code="subField">Kingdom of Saudi Arabia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Perlman, Stanley" sort="Perlman, Stanley" uniqKey="Perlman S" first="Stanley" last="Perlman">Stanley Perlman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA stanley-perlman@uiowa.edu aalagaili@ksu.edu.sa.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alagaili, Abdulaziz N" sort="Alagaili, Abdulaziz N" uniqKey="Alagaili A" first="Abdulaziz N" last="Alagaili">Abdulaziz N. Alagaili</name>
<affiliation wicri:level="1">
<nlm:affiliation>KSU Mammals Research Chair, Zoology Department, King Saud University, Riyadh, Kingdom of Saudi Arabia stanley-perlman@uiowa.edu aalagaili@ksu.edu.sa.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>KSU Mammals Research Chair, Zoology Department, King Saud University, Riyadh</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">mBio</title>
<idno type="eISSN">2150-7511</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Neutralizing (blood)</term>
<term>Antibodies, Viral (blood)</term>
<term>Camelus</term>
<term>Cohort Studies</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Disease Transmission, Infectious</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Fluorescent Antibody Technique</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus (immunology)</term>
<term>Neutralization Tests</term>
<term>Occupational Diseases (epidemiology)</term>
<term>Occupational Exposure</term>
<term>Saudi Arabia (epidemiology)</term>
<term>Seroepidemiologic Studies</term>
<term>T-Lymphocytes (immunology)</term>
<term>Zoonoses (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps antiviraux (sang)</term>
<term>Anticorps neutralisants (sang)</term>
<term>Arabie saoudite (épidémiologie)</term>
<term>Chameaux</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (immunologie)</term>
<term>Exposition professionnelle</term>
<term>Humains</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Lymphocytes T (immunologie)</term>
<term>Maladies professionnelles (épidémiologie)</term>
<term>Technique d'immunofluorescence</term>
<term>Test ELISA</term>
<term>Tests de neutralisation</term>
<term>Transmission de maladie infectieuse</term>
<term>Zoonoses (épidémiologie)</term>
<term>Études de cohortes</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Neutralizing</term>
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Saudi Arabia</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Occupational Diseases</term>
<term>Zoonoses</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Lymphocytes T</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antiviraux</term>
<term>Anticorps neutralisants</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Arabie saoudite</term>
<term>Infections à coronavirus</term>
<term>Maladies professionnelles</term>
<term>Zoonoses</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Camelus</term>
<term>Cohort Studies</term>
<term>Disease Transmission, Infectious</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Fluorescent Antibody Technique</term>
<term>Humans</term>
<term>Neutralization Tests</term>
<term>Occupational Exposure</term>
<term>Seroepidemiologic Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Chameaux</term>
<term>Exposition professionnelle</term>
<term>Humains</term>
<term>Technique d'immunofluorescence</term>
<term>Test ELISA</term>
<term>Tests de neutralisation</term>
<term>Transmission de maladie infectieuse</term>
<term>Études de cohortes</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Arabie saoudite</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Middle East respiratory syndrome (MERS), a highly lethal respiratory disease caused by a novel coronavirus (MERS-CoV), is an emerging disease with high potential for epidemic spread. It has been listed by the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) as an important target for vaccine development. While initially the majority of MERS cases were hospital acquired, continued emergence of MERS is attributed to community acquisition, with camels likely being the direct or indirect source. However, the majority of patients do not describe camel exposure, making the route of transmission unclear. Here, using sensitive immunological assays and a cohort of camel workers (CWs) with well-documented camel exposure, we show that approximately 50% of camel workers (CWs) in the Kingdom of Saudi Arabia (KSA) and 0% of controls were previously infected. We obtained blood samples from 30 camel herders, truck drivers, and handlers with well-documented camel exposure and from healthy donors, and measured MERS-CoV-specific enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and neutralizing antibody titers, as well as T cell responses. Totals of 16/30 CWs and 0/30 healthy control donors were seropositive by MERS-CoV-specific ELISA and/or neutralizing antibody titer, and an additional four CWs were seronegative but contained virus-specific T cells in their blood. Although virus transmission from CWs has not been formally demonstrated, a possible explanation for repeated MERS outbreaks is that CWs develop mild disease and then transmit the virus to uninfected individuals. Infection of some of these individuals, such as those with comorbidities, results in severe disease and in the episodic appearance of patients with MERS.
<b>IMPORTANCE</b>
The Middle East respiratory syndrome (MERS) is a coronavirus (CoV)-mediated respiratory disease. Virus transmission occurs within health care settings, but cases also appear sporadically in the community. Camels are believed to be the source for community-acquired cases, but most patients do not have camel exposure. Here, we assessed whether camel workers (CWs) with high rates of exposure to camel nasal and oral secretions had evidence of MERS-CoV infection. The results indicate that a high percentage of CWs were positive for virus-specific immune responses but had no history of significant respiratory disease. Thus, a possible explanation for repeated MERS outbreaks is that CWs develop mild or subclinical disease. These CWs then transmit the virus to uninfected individuals, some of whom are highly susceptible, develop severe disease, and are detected as primary MERS cases in the community.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30377284</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>02</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2150-7511</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>9</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2018</Year>
<Month>10</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>mBio</Title>
<ISOAbbreviation>mBio</ISOAbbreviation>
</Journal>
<ArticleTitle>High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e01985-18</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.01985-18</ELocationID>
<Abstract>
<AbstractText>Middle East respiratory syndrome (MERS), a highly lethal respiratory disease caused by a novel coronavirus (MERS-CoV), is an emerging disease with high potential for epidemic spread. It has been listed by the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) as an important target for vaccine development. While initially the majority of MERS cases were hospital acquired, continued emergence of MERS is attributed to community acquisition, with camels likely being the direct or indirect source. However, the majority of patients do not describe camel exposure, making the route of transmission unclear. Here, using sensitive immunological assays and a cohort of camel workers (CWs) with well-documented camel exposure, we show that approximately 50% of camel workers (CWs) in the Kingdom of Saudi Arabia (KSA) and 0% of controls were previously infected. We obtained blood samples from 30 camel herders, truck drivers, and handlers with well-documented camel exposure and from healthy donors, and measured MERS-CoV-specific enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and neutralizing antibody titers, as well as T cell responses. Totals of 16/30 CWs and 0/30 healthy control donors were seropositive by MERS-CoV-specific ELISA and/or neutralizing antibody titer, and an additional four CWs were seronegative but contained virus-specific T cells in their blood. Although virus transmission from CWs has not been formally demonstrated, a possible explanation for repeated MERS outbreaks is that CWs develop mild disease and then transmit the virus to uninfected individuals. Infection of some of these individuals, such as those with comorbidities, results in severe disease and in the episodic appearance of patients with MERS.
<b>IMPORTANCE</b>
The Middle East respiratory syndrome (MERS) is a coronavirus (CoV)-mediated respiratory disease. Virus transmission occurs within health care settings, but cases also appear sporadically in the community. Camels are believed to be the source for community-acquired cases, but most patients do not have camel exposure. Here, we assessed whether camel workers (CWs) with high rates of exposure to camel nasal and oral secretions had evidence of MERS-CoV infection. The results indicate that a high percentage of CWs were positive for virus-specific immune responses but had no history of significant respiratory disease. Thus, a possible explanation for repeated MERS outbreaks is that CWs develop mild or subclinical disease. These CWs then transmit the virus to uninfected individuals, some of whom are highly susceptible, develop severe disease, and are detected as primary MERS cases in the community.</AbstractText>
<CopyrightInformation>Copyright © 2018 Alshukairi et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Alshukairi</LastName>
<ForeName>Abeer N</ForeName>
<Initials>AN</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudia Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Zheng</LastName>
<ForeName>Jian</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Zhao</LastName>
<ForeName>Jingxian</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nehdi</LastName>
<ForeName>Atef</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baharoon</LastName>
<ForeName>Salim A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Department of Critical Care, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Layqah</LastName>
<ForeName>Laila</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bokhari</LastName>
<ForeName>Ahmad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al Johani</LastName>
<ForeName>Sameera M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>College of Science and Health Professions, King Saud Bin Abdulaziz for Health Sciences University, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Samman</LastName>
<ForeName>Nosaibah</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boudjelal</LastName>
<ForeName>Mohamad</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Research Core Facility and Platforms, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ten Eyck</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Al-Mozaini</LastName>
<ForeName>Maha A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Department of Infection and Immunology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Zhao</LastName>
<ForeName>Jincun</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Guangzhou Eighth People's Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Perlman</LastName>
<ForeName>Stanley</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0003-4213-2354</Identifier>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA stanley-perlman@uiowa.edu aalagaili@ksu.edu.sa.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Alagaili</LastName>
<ForeName>Abdulaziz N</ForeName>
<Initials>AN</Initials>
<AffiliationInfo>
<Affiliation>KSU Mammals Research Chair, Zoology Department, King Saud University, Riyadh, Kingdom of Saudi Arabia stanley-perlman@uiowa.edu aalagaili@ksu.edu.sa.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P01 AI060699</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI129269</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>10</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>mBio</MedlineTA>
<NlmUniqueID>101519231</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002162" MajorTopicYN="N">Camelus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018562" MajorTopicYN="N">Disease Transmission, Infectious</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009784" MajorTopicYN="N">Occupational Diseases</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016273" MajorTopicYN="Y">Occupational Exposure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015047" MajorTopicYN="N">Zoonoses</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Middle East respiratory syndrome</Keyword>
<Keyword MajorTopicYN="Y">T cells</Keyword>
<Keyword MajorTopicYN="Y">antibody</Keyword>
<Keyword MajorTopicYN="Y">camel workers</Keyword>
<Keyword MajorTopicYN="Y">coronavirus</Keyword>
<Keyword MajorTopicYN="Y">human Middle East respiratory syndrome</Keyword>
<Keyword MajorTopicYN="Y">virus-specific T cell response</Keyword>
<Keyword MajorTopicYN="Y">virus-specific antibody response</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>11</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30377284</ArticleId>
<ArticleId IdType="pii">mBio.01985-18</ArticleId>
<ArticleId IdType="doi">10.1128/mBio.01985-18</ArticleId>
<ArticleId IdType="pmc">PMC6212820</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Influenza Other Respir Viruses. 2015 Mar;9(2):64-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25470665</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zoonoses Public Health. 2016 Feb;63(1):1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25545147</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Oct 2;371(14):1359-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25271615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2011 Jun 15;186(12):7264-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21576510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2016 Jun;22(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27192543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2013 Dec;19(12):2034-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24274664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9081-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27457935</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Jun 26;370(26):2499-505</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24896817</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2016 Apr 12;34(17):2008-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26954467</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2002 Jun 1;168(11):5954-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12023402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2014 Dec;20(12):2093-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25425139</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2006 Dec 25;203(13):2865-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17158960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2013 Aug;67(2):130-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23583636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Aug 28;371(9):828-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25162889</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2016 Mar 15;213(6):904-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26203058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2017 Sep 11;17(1):615</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28893197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2015 Apr;21(4):699-701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25811546</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet J. 2017 Feb;220:75-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28190501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Immunol. 2018 Jan 19;3(19):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29352091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2018 Aug 13;10(8):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30104551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2016 Jan 1;351(6268):81-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26678874</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 Jan 15;209(2):243-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24218504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MBio. 2014 Feb 25;5(2):e00884-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24570370</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Immunol. 2017 Aug 4;2(14):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28778905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2015 Sep 5;386(9997):995-1007</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26049252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26195744</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Immunol. 2013 Nov 15;25(4):273-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24246226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Infect Control. 2018 Feb;46(2):165-168</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28958446</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2015 Aug;21(8):1422-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26196891</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2018 Aug;18(8):e217-e227</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29680581</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2015 May;15(5):559-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25863564</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000743 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000743 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:30377284
   |texte=   High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:30377284" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021